Press Releases
Gather China & World Pharmaceutical Entrepreneurs,Create a New Chapter...
CPhI& P-MEC China will be held in Shanghai New International Expo Center on June 21-23, 2016.Bearing 15-year trust of the industry, CPhI& P-MEC China continuously...
Press Releases
Kyowa Hakko Kirin Announces Commencement of Phase 2 Clinical...
Bardoxolone Methyl (RTA 402) Data Show Improvement in Renal Function by Inulin Clearance in a Phase II Clinical Study in Japan Kyowa Hakko Kirin Co.,...
Press Releases
CHAMPIX European Union Label Updated To Include New Safety...
Pfizer Inc announced that the European Summary of Product Characteristics (SmPC) and Package Leaflet for CHAMPIX® (varenicline) have been updated to include safety and efficacy...
Press Releases
Boehringer Ingelheim and BioMed X start new project...
Aims to identify maladaptive brain circuits to find new approaches for treating psychiatric diseases Second Boehringer Ingelheim crowdsourcing project with BioMed X builds...
Press Releases
Mylan NV Launches First Generic Doryx Delayed-Release Tablets, 200...
Mylan N.V. announced the U.S. launch of Doxycycline Hyclate Delayed-Release (DR) Tablets USP, 200 mg, a generic version of Mayne's Doryx®. Mylan received final approval...
Press Releases
Allergan Launches IBS-D on Tract, New Online Resource to...
IBSDonTract.com provides clear information, symptom management strategies and interactive tools for people with IBS-D, which affects up to 15 million adults in the U.S.Allergan plc...
Press Releases
Pfizer Inc Announces EMA acceptance for Trumenba (Meningococcal Group...
Pfizer Inc announced the European Medicines Agency (EMA) has accepted the Marketing Authorization Application (MAA) for TRUMENBA® (Meningococcal Group B Vaccine) for review. ...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.